Literature DB >> 33107647

Prodromal Spinocerebellar Ataxia Type 2 Subjects Have Quantifiable Gait and Postural Sway Deficits.

Luis Velázquez-Pérez1,2, Roberto Rodriguez-Labrada1,3, Yasmani González-Garcés1, Eduardo Arrufat-Pie4, Reidenis Torres-Vega1, Jacqueline Medrano-Montero1, Beatriz Ramirez-Bautista5, Yaimeé Vazquez-Mojena1,3, Georg Auburger6, Fay Horak7, Ulf Ziemann8,9, Christopher M Gomez10.   

Abstract

BACKGROUND: The search for valid preclinical biomarkers of cerebellar dysfunction is a key research goal for the upcoming era of early interventional approaches in spinocerebellar ataxias. This study aims to describe novel preclinical biomarkers of subtle gait and postural sway abnormalities in prodromal spinocerebellar ataxia type 2 (pre-SCA2).
METHODS: Thirty pre-SCA2 patients and their matched healthy controls underwent quantitative assessments of gait and postural sway using a wearable sensor-based system and semiquantitative evaluation of cerebellar features by SARA (Scale for the Assessment and Rating of Ataxia) score.
RESULTS: Quantitative analysis of natural gait showed a significantly larger variability of the swing period, toe-off angle and toe-out angle in pre-SCA2, and larger mean coronal and transverse ranges of motion of the trunk at the lumbar location and of the sagittal range of motion of the trunk at the sternum location compared to controls. During tandem gait, pre-SCA2 subjects showed larger lumbar, trunk, and arm ranges of motion than controls. Postural sway analysis showed excessive body oscillation that was increased in tandem stance. Overall, these abnormalities were detected in pre-SCA2 patients without clinical evidence of abnormalities in SARA. The toe-off angle and swing time variability were significantly correlated with the time to ataxia onset, whereas the toe-off angle and transverse range of motion at trunk position during tandem gait were significantly associated with the SARA score.
CONCLUSIONS: This study demonstrates early alteration of gait and postural sway control in prodromal SCA2 using a wearable sensor-based system. This offers new pathophysiological hints into this early disease stage and provides novel potential biomarkers for future clinical trials.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  body-worn inertial measurement units; gait abnormalities; postural control deficits; prodromal stage; spinocerebellar ataxia type 2

Mesh:

Year:  2020        PMID: 33107647     DOI: 10.1002/mds.28343

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  Consensus Paper: Ataxic Gait.

Authors:  Pierre Cabaraux; Sunil K Agrawal; Huaying Cai; Rocco Salvatore Calabro; Carlo Casali; Loic Damm; Sarah Doss; Christophe Habas; Anja K E Horn; Winfried Ilg; Elan D Louis; Hiroshi Mitoma; Vito Monaco; Maria Petracca; Alberto Ranavolo; Ashwini K Rao; Serena Ruggieri; Tommaso Schirinzi; Mariano Serrao; Susanna Summa; Michael Strupp; Olivia Surgent; Matthis Synofzik; Shuai Tao; Hiroo Terasi; Diego Torres-Russotto; Brittany Travers; Jaimie A Roper; Mario Manto
Journal:  Cerebellum       Date:  2022-04-12       Impact factor: 3.847

2.  Intelligent wearable allows out-of-the-lab tracking of developing motor abilities in infants.

Authors:  Manu Airaksinen; Anastasia Gallen; Anna Kivi; Pavithra Vijayakrishnan; Taru Häyrinen; Elina Ilén; Okko Räsänen; Leena M Haataja; Sampsa Vanhatalo
Journal:  Commun Med (Lond)       Date:  2022-06-15

3.  The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?

Authors:  Hiroshi Mitoma; Kazuhiko Yamaguchi; Jerome Honnorat; Mario Manto
Journal:  Brain Sci       Date:  2022-02-24

4.  Digital endpoints for self-administered home-based functional assessment in pediatric Friedreich's ataxia.

Authors:  Arne Mueller; Elaine Paterson; Avery McIntosh; Jens Praestgaard; Mary Bylo; Holger Hoefling; McKenzie Wells; David R Lynch; Christian Rummey; Michelle L Krishnan; Meredith Schultz; C J Malanga
Journal:  Ann Clin Transl Neurol       Date:  2021-08-06       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.